Drugs to lose weight could add years to the lives of Americans, researchers project

A new study has discovered that diabetes medications and weight loss could significantly reduce mortality for Americans.

Swiss Re researchers, a reinsurance company in Zurich, Switzerland, published estimates that GLP-1 medications could lead to a 6.4% reduction in mortality from all causes in the United States by 2045.

In the United Kingdom, more than 5% reduction in mortality was projected in the same 20 years.

Could GLP-1 weight loss medications like Ozempic become the ‘drug of everything’?

The United States and the United Kingdom share high rates of obesity and a “strong absorption” in GLP-1 medicines, the researchers said in a press release.

The United States has the highest obesity rate in the world, since more than 40% of the adult population is Obesa. About 30% of the United Kingdom adults are obese.

Obesity is a factor that has “stagnated progress in life expectancy”, since it is linked to 70% of the main causes of death in high -income countries, according to researchers. These causes include heart disease, stroke, Alzheimer’s and many cancers.

“By improving basal risk factors, GLP-1 medications can contribute to mortality improvements over time, saving millions of premature death,” the researchers said.

Why ozempic microdosis could be as common as taking a multivitamin

To maximize the benefits of GLP-1 medicines, people must also implement lifestyle changes that support “long-term health improvements,” experts advised.

Without sustainable changes, such as diet and exercise, the effects of recovery and rebound are common, according to studies.

Paul Murray, the CEO of Swiss Re of Life & Health Reaseguro, commented on these findings in a press release, pointing out that GLP-1 drugs have “a significant promise to help us overcome the epidemic of obesity.”

Click here to get the News application

“Our research emphasizes that the full benefit will come from going beyond medicines,” he wrote. “As insurers, we are able to build associations, support politics and encourage people to make significant changes in lifestyle with an approach to prevention.”

Murray added: “If we achieve this well, we can strengthen the insurance security network and contribute to people who live longer and healthier lives.”

Click here to register in our health newsletter

Recent research has revealed that GLP-1 medications can improve a variety of conditions beyond weight loss and diabetes.

These include hearts, kidney, liver and skin, as well as arthritis, cognitive impairment, addiction and even certain cancers.

The medical of weight loss certified by the Triple Board, Dr. Sue Decotiis, based in New York, confirmed in an interview with News Digital how patients have experienced an improvement in various conditions while they are in these medications.

Fat cells, which are burned by an increase in the insulin of GLP-1 medications, produce cytokines that are responsible for inflammation in the body, which potentially leads to autoimmune diseases, cancer and other problems, according to the expert.

For more health articles, visit www.Newsnews.com/health

“By reducing the volume of fat cells in the body, we reduce all these inflammatory cytokines,” he said. “And that’s why we see many of the effects we see.”

“It is important to do it in the right way and really treat these medications with respect, treat their body with respect and understand that this is a wonderful tool if used in the right way.”